Journal Club E08: Head-to-Head: Apixaban vs Rivaroxaban for Acute VTE , The COBRRA Trial

from AZense Journal Club · host Azense Medical Education

COBRRA: Apixaban Has Half the Bleeding Risk of Rivaroxaban in Acute Venous Thromboembolism

Episode metadata supplied by the publisher feed · Published May 26, 2025

Embed this episode

Attribution link and audio player

Ready to play

Journal Club E08: Head-to-Head: Apixaban vs Rivaroxaban for Acute VTE , The COBRRA Trial

0:00 6:12

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 6 minutes long.

This episode was published on May 26, 2025.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!